菲律宾日本脑炎疫苗接种:不同接种策略的成本效果分析
该研究从社会与政府视角,用马尔可夫模型比较菲律宾三种儿童日本脑炎疫苗接种策略与不接种的成本效果。全国常规接种、次国家级活动后常规接种、全国活动后常规接种的每避免一个伤残调整生命年成本分别为233至265美元(政府视角)和29至57美元(社会视角),均具成本效果。
要点
- 全国活动后全国常规接种最具成本效果,每避免一个DALY成本为政府视角233美元、社会视角29美元。
- 20个连续出生队列中,接种预计可预防27,856至37,277例病例、5,571至7,455例死亡。
- 所有接种策略每避免一个DALY成本为政府视角233至265美元、社会视角29至57美元。
核心结论
- 在菲律宾使用CD-JEV接种预计具有成本效果,与不接种相比可降低日本脑炎的长期费用并改善健康结局。
研究设计与样本
- 成本效果分析,从社会与政府视角比较三种接种策略与不接种,使用马尔可夫模型估算终身影响,假设年发病率为每10万例10.6例。
- 策略包括:全国常规接种、次国家级活动后全国常规接种、全国活动后全国常规接种。
主要发现
- 全国活动后全国常规接种最具成本效果,每避免一个DALY成本为政府视角233美元、社会视角29美元。
- 其他策略每避免一个DALY成本为政府视角233至265美元、社会视角29至57美元。
- 接种预计在20个连续出生队列中预防27,856至37,277例病例、5,571至7,455例死亡、173,233至230,704个DALY。
关键数值与推荐
- 疾病成本为每例859美元,疫苗为每剂0.50美元,常规接种为每剂0.95美元,活动接种为每剂0.98美元。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Japanese encephalitis (JE) is a mosquito-borne viral infection of the brain that can cause permanent brain damage and death. In the Philippines, efforts are underway to deliver a live attenuated JE vaccine (CD-JEV) to children under five years of age (YOA), who are disproportionately infected. Multiple vaccination strategies are being considered. METHODS: We conducted a cost-effectiveness analysis comparing three vaccination strategies to the current state of no vaccination from the societal and government perspectives: (1) national routine vaccination only, (2) sub-national campaign followed by national routine, and (3) national campaign followed by national routine. We developed a Markov model to estimate impact of vaccination or no vaccination over the child's lifetime horizon, assuming an annual incidence of 10.6 cases per 100,000. Costs of illness ($859/case), vaccine ($0.50/dose), routine vaccination ($0.95/dose), and campaign vaccination ($0.98/dose) were based on hospital financial records, expert opinion and literature. The societal perspective included transportation and opportunity costs of caregiver time, in addition to costs incurred by the health system. RESULTS: JE vaccination via national campaign followed by national routine delivery was the most cost-effective strategy modeled with a cost per disability adjusted life year (DALY) averted of $233 and $29 from the government and societal perspectives, respectively. Results were similar for other delivery strategies with cost/DALY ranging from $233 to $265 from the government perspective and $29-$57 from the societal perspective. JE vaccination was projected to prevent 27,856-37,277 cases, 5571-7455 deaths, and 173,233-230,704 DALYs among children under five over 20 consecutive birth cohorts. Total incremental costs of vaccination versus no vaccination over 20 birth cohorts were $6.6-$9.8 million from the societal perspective ($230 K-$440 K annually) and $45.9-$53.9 million ($2.2 M-$2.7 M annually) from the governmental perspective. CONCLUSION: Vaccination with CD-JEV in the Philippines is projected to be cost-effective, reducing long-term costs associated with JE illness and improving health outcomes compared to no vaccination.
引用
- Vodicka E, Zimmermann M, Lopez AL, et al. Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies. Vaccine. 2020. PMID: 32085954. doi:10.1016/j.vaccine.2020.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。